Impaired immune response to vaccinia virus inoculated at the site of cutaneous allergic inflammation

Journal of Allergy and Clinical Immunology

Volumn 120, Issue 6, 2007, Pages 1382-1388

  Scott, Jordan E ^a   ElKhal, Abdallah ^a   Freyschmidt, Eva Jasmin ^a   MacArthur, Daniel H ^a   McDonald, Douglas ^a   Howell, Michael D ^c   Leung, Donald Y M ^c   Laouar, Amale ^b   Manjunath, N ^b   Bianchi, Teresa ^d   Boes, Marianne ^d   Oettgen, Hans C ^a   Geha, Raif S ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

allergy; Eczema vaccinatum; smallpox vaccination; TH1 TH2 cells; vaccinia virus; viral response

Indexed keywords

ALPHA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; INOCULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN ALLERGY; SPLEEN CELL; UPREGULATION; VACCINIA VIRUS; VIRUS STRAIN;

ANIMALS; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; FEMALE; KAPOSI VARICELLIFORM ERUPTION; MICE; MICE, INBRED BALB C; VACCINIA; VACCINIA VIRUS;

EID: 36749017671     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.08.004     Document Type: Article

References (33)

1. Esposito J.J., and Fenner F. Poxviruses. In: Knipe D.M., and Howley P.M. (Eds). Fields virology (2001), Lippincott Williams & Wilkins, Philadelphia 2885-2922
2. Lane J.M., Ruben F.L., Abrutyn E., and Millar J.D. Deaths attributable to smallpox vaccination, 1959 to 1966, and 1968. JAMA 212 (1970) 441-444
3. Neff J.M., Lane J.M., Fulginiti V.A., and Henderson D.A. Contact vaccinia: transmission of vaccinia from smallpox vaccination. JAMA 288 (2002) 1901-1905
4. Lane J.M., and Millar J.D. Risks of smallpox vaccination complications in the United States. Am J Epidemiol 93 (1971) 238-240
5. Shirasawa K., Akai K., Kawaguchi Y., Maeda S., Nagahara S., Toyoda H., et al. Widespread eczema vaccinatum acquired by contacts: a report of an autopsy case. Acta Pathol Jpn 29 (1979) 435-455
6. Marris E. Dramatic rescue relieves rare case of smallpox infection. Nat Med 13 (2007) 517
7. Leung D.Y., and Bieber T. Atopic dermatitis. Lancet 361 (2003) 151-160
8. Karupiah G., Blanden R.V., and Ramshaw I.A. Interferon gamma is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin 2 infection. J Exp Med 172 (1990) 1495-1503
9. Xu R., Johnson A.J., Liggitt D., and Bevan M.J. Cellular and humoral immunity against vaccinia virus infection of mice. J Immunol 172 (2004) 6265-6271
10. Kohonen-Corish M.R., King N.J., Woodhams C.E., and Ramshaw I.A. Immunodeficient mice recover from infection with vaccinia virus expressing interferon-gamma. Eur J Immunol 20 (1990) 157-161
11. Sharma D.P., Ramsay A.J., Maguire D.J., Rolph M.S., and Ramshaw I.A. Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo. J Virol 70 (1996) 7103-7107
12. van Den Broek M., Bachmann M.F., Kohler G., Barner M., Escher R., Zinkernagel R., et al. IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN-gamma and nitric oxide synthetase 2. J Immunol 164 (2000) 371-378
13. Spergel J.M., Mizoguchi E., Brewer J.P., Martin T.R., Bhan A.K., and Geha R.S. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest 101 (1998) 1614-1622
14. Spergel J.M., Mizoguchi E., Oettgen H., Bhan A.K., and Geha R.S. Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. J Clin Invest 103 (1999) 1103-1111
15. Laouini D., Elkhal A., Yalcindag A., Kawamoto S., Oettgen H., and Geha R.S. COX-2 inhibition enhances the TH2 immune response to epicutaneous sensitization. J Allergy Clin Immunol 116 (2005) 390-396
16. Phelps A.L., Gates A.J., Hillier M., Eastaugh L., and Ulaeto D.O. Comparative efficacy of modified vaccinia Ankara (MVA) as a potential replacement smallpox vaccine. Vaccine 25 (2007) 34-42
17. In: Earl P.L., Cooper N., Wyatt L.S., Moss B., and Carroll M.W. (Eds). Preparation of cell cultures and vaccinia virus stocks (1998), John Wiley & Sons, Inc, Mississauga, Ontario, Canada
18. Freyschmidt E.J., Mathias C.B., Macarthur D.H., Laouar A., Narasimhaswamy M., Weih F., et al. Skin inflammation in RelB(-/-) mice leads to defective immunity and impaired clearance of vaccinia virus. J Allergy Clin Immunol 119 (2007) 671-679
19. Elkhal A., Pichavant M., He R., Scott J., Meyer E., Goya S., et al. CD1d restricted natural killer T cells are not required for allergic skin inflammation. J Allergy Clin Immunol 118 (2006) 1363-1368
20. Ennis F.A., Cruz J., Demkowicz Jr. W.E., Rothman A.L., and McClain D.J. Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination. J Infect Dis 185 (2002) 1657-1659
21. Huang S., Hendriks W., Althage A., Hemmi S., Bluethmann H., Kamijo R., et al. Immune response in mice that lack the interferon-gamma receptor. Science 259 (1993) 1742-1745
22. Snapper C.M., and Paul W.E. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236 (1987) 944-947
23. Howell M.D., Jones J.F., Kisich K.O., Streib J.E., Gallo R.L., and Leung D.Y. Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum. J Immunol 172 (2004) 1763-1767
24. Ong P.Y., Ohtake T., Brandt C., Strickland I., Boguniewicz M., Ganz T., et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347 (2002) 1151-1160
25. Howell M.D., Gallo R.L., Boguniewicz M., Jones J.F., Wong C., Streib J.E., et al. Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity 24 (2006) 341-348
26. Davidson D.J., Currie A.J., Reid G.S., Bowdish D.M., MacDonald K.L., Ma R.C., et al. The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J Immunol 172 (2004) 1146-1156
27. van den Broek M.F., Muller U., Huang S., Zinkernagel R.M., and Aguet M. Immune defence in mice lacking type I and/or type II interferon receptors. Immunol Rev 148 (1995) 5-18
28. Manetti R., Annunziato F., Tomasevic L., Gianno V., Parronchi P., Romagnani S., et al. Polyinosinic acid: polycytidylic acid promotes T helper type 1-specific immune responses by stimulating macrophage production of interferon-alpha and interleukin-12. Eur J Immunol 25 (1995) 2656-2660
29. Wollenberg A., Wagner M., Gunther S., Towarowski A., Tuma E., Moderer M., et al. Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases. J Invest Dermatol 119 (2002) 1096-1102
30. Guttman-Yassky E., Lowes M.A., Fuentes-Duculan J., Whynot J., Novitskaya I., Cardinale I., et al. Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis. J Allergy Clin Immunol 119 (2007) 1210-1217
31. Karupiah G., Xie Q.W., Buller R.M., Nathan C., Duarte C., and MacMicking J.D. Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science 261 (1993) 1445-1448
32. Hogg K.G., Kumkate S., Anderson S., and Mountford A.P. Interleukin-12 p40 secretion by cutaneous CD11c+ and F4/80+ cells is a major feature of the innate immune response in mice that develop Th1-mediated protective immunity to Schistosoma mansoni. Infect Immun 71 (2003) 3563-3571
33. Barton D., HogenEsch H., and Weih F. Mice lacking the transcription factor RelB develop T cell-dependent skin lesions similar to human atopic dermatitis. Eur J Immunol 30 (2000) 2323-2332